BIOXCEL THERAPEUTICS INC
(NASDAQ: BTAI)

BioXcel Therapeutics, Inc. is a biopharmaceutical company, which engages in the development of artificial intelligence solutions in neuroscience and immuno-oncology. It also focuses on utilizing technology and research to develop therapeutics solutions. The company was founded by Vimal D. Mehta on March 29, 2017 and is headquartered in New Haven, CT.

2.560

-0.030 (-1.16%)
Range 2.550 - 2.631   (3.18%)
Open -
Previous Close 2.590
Bid Price 25.000
Bid Volume 10
Ask Price 27.000
Ask Volume 10
Volume 244,513
Value -
Remark
Delayed prices. Updated at 19 Apr 2024 03:45.
Data powered by
View All Events

Loading Chart...

Please login to view stock data and analysis